Full Text View
Tabular View
No Study Results Posted
Related Studies
Arsenic Trioxide in Treating Patients With Recurrent Bladder or Urinary Tract Cancer
This study has been completed.
Study NCT00009867   Information provided by Cancer and Leukemia Group B
First Received: February 2, 2001   Last Updated: April 1, 2011   History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study
About Study Results Reporting on ClinicalTrials.gov
  Study Status: This study has been completed.
  Study Completion Date: April 2009
  Primary Completion Date: June 2004 (Final data collection date for primary outcome measure)
Publications:
Bajorin DF, Halabi S, Small E. Arsenic Trioxide in Recurrent Urothelial Cancer: A Cancer and Leukemia Group B Phase II Trial (CALGB 99903). Clin Genitourin Cancer. 2009 Oct 1;7(3):E66-E70.




Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services